ArticleMolecular therapy. Methods & clinical development2025

Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study.

Robert Klamroth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.